EuroPCR 2012

EuroPCR | May 15-18, 2012

Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Biodegradable Stents Hold Up

PARIS — The next generation of drug-eluting stents that do a disappearing act, whether with a biodegradable polymer or an entirely bioabsorbable platform, appears to be holding up to conventional stents over the short term.
- Read More
'Parachute' Promising for Heart Failure

PARIS — A percutaneous device that walls off part of the left ventricle to help failing hearts appears to have a big impact on outcomes, pilot study results showed.
- Read More
Bigger BP Drop Goal for Renal Denervation

PARIS — More dramatic blood pressure reductions may be on the horizon for patients with resistant hypertension given the phalanx of renal denervation systems under development.
- Read More

Statins Before Stenting Cut Risks

PARIS — Statin treatment before percutaneous coronary intervention reduces cardiac injury from the procedure and boosts longer- term outcomes, Italian researchers affirmed.
- Read More
'Virtual Stenting' Aids PCI Planning

PARIS — Computer projections of the impact of stenting on cardiac ischemia measured by a specialized CT imaging technique appear accurate and could help with planning out placement, researchers found.
- Read More

Valve-in-Valve TAVI Tricky, But It Works

PARIS — Transcatheter replacement of failing bioprosthetic aortic valves is usually successful but likely should be left to the most expert hands, researchers suggested.
- Read More
Novel Stent Safer in MI

PARIS — A novel drug-eluting stent appears to substantially improve outcomes for heart attack patients more than a bare-metal stent, researchers found.
- Read More

Ischemia-Guided Stenting Beats Meds Alone

PARIS — For patients with proven ischemia, stenting substantially cuts the revascularization rate compared with optimal medical therapy alone, preliminary trial results showed.
- Read More

Fractional Flow in Focus at EuroPCR

PARIS — Ischemia-guided therapy for multivessel coronary artery disease interventions may be the show-stealer at this year's EuroPCR meeting here.
- Read More